Altus CEO Resigns

February 12, 2008
BioPharm International Editors

Sheldon Berkle has resigned as president, chief executive officer, and member of the board of directors of Altus Pharmaceuticals, Inc. (Cambridge, MA).

Sheldon Berkle has resigned as president, chief executive officer, and member of the board of directors of Altus Pharmaceuticals, Inc. (Cambridge, MA). David D. Pendergast, PhD, has been appointed to the interim position of executive chairman while the company initiates a search for a new president and chief executive officer.

Altus announcement

Related Content:

News